Clinical Trial Update: PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial is evaluating whether PIVKA-II can predict portal vein tumor thrombosis in hepatocellular carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Tumor Thrombosis

Snippet

Sponsor: Tanta University | Conditions: Hepato Cellular Carcinoma (HCC), Portal Vein Tumour Thrombosis | Status: RECRUITING